NYT > Research: Business Briefing | Regulatory News: Tentative Approval for Faster-Acting Hepatitis C Drug

Business Briefing | Regulatory News: Tentative Approval for Faster-Acting Hepatitis C Drug

Advisers to the Food and Drug Administration unanimously voted in favor of a hepatitis C drug from Gilead Sciences.

Source: http://www.nytimes.com/2013/10/26/business/tentative-approval-for-faster-acting-hepatitis-c-drug.html?partner=rss&emc=rss